These results are consistent with a previous study that analyzed IL-1β in the serum of 71 COVID-19 patients showing that there was no statistical significant difference in IL-1β levels between COVID-19 patients who survived and those who died, suggesting that IL-1β levels in blood do not correlate with disease severity (31). The gene discussed is IL1B; the disease is COVID-19.